Malvern-based Endo has agreed to merge with Mallinckrodt in a cash and stock deal, valuing the combined pharmaceutical company at $6.7 billion, writes ...
After the quarterly review of the Model Shadow Stock Portfolio at the beginning of March, one stock is being removed and one stock is being added.
The JPMorgan CEO tells the truth about Glass Lewis and ISS.
Kolte-Patil said on March 13 it will allot a Blackstone entity 14.3% preferential shares in a deal worth 4.17 billion rupees, ...